BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37861207)

  • 1. Human papillomavirus and p16
    Lu Y; Clifford GM; Fairley CK; Grulich AE; Garland SM; Xiao F; Wang Y; Zou H
    Int J Cancer; 2024 Mar; 154(5):830-841. PubMed ID: 37861207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of human papillomavirus DNA and p16
    Li Z; Liu P; Wang Z; Zhang Z; Chen Z; Chu R; Li G; Han Q; Zhao Y; Li L; Miao J; Kong B; Song K
    Lancet Oncol; 2023 Apr; 24(4):403-414. PubMed ID: 36933562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus DNA and p16
    Olesen TB; Sand FL; Rasmussen CL; Albieri V; Toft BG; Norrild B; Munk C; Kjær SK
    Lancet Oncol; 2019 Jan; 20(1):145-158. PubMed ID: 30573285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis.
    Ndiaye C; Mena M; Alemany L; Arbyn M; Castellsagué X; Laporte L; Bosch FX; de Sanjosé S; Trottier H
    Lancet Oncol; 2014 Nov; 15(12):1319-31. PubMed ID: 25439690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prevalence of Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma at One of the Largest Tertiary Care Centers in Sub-Saharan Africa.
    Dapaah G; Hille J; Faquin WC; Whittaker J; Dittrich CM; Ebrahim AK; Schneider JW; van Wyk AC; Opperman J; Merven M; Naidoo K; Loock JW; Afrogheh AH
    Arch Pathol Lab Med; 2022 Aug; 146(8):1018-1023. PubMed ID: 34871360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic accuracy of p16
    Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
    Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of discordant human papillomavirus and p16 oropharyngeal squamous cell carcinomas in an African American cohort.
    Liu JC; Parajuli S; Blackman E; Gibbs D; Ellis A; Hull A; Beck JR; Giri V; Iherjirka P; Khurana JS; Ragin CR
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E867-72. PubMed ID: 25962720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus.
    Patel KR; Chernock RD; Zhang TR; Wang X; El-Mofty SK; Lewis JS
    Hum Pathol; 2013 Nov; 44(11):2385-92. PubMed ID: 24071016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
    Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
    Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma.
    Young RJ; Urban D; Angel C; Corry J; Lyons B; Vallance N; Kleid S; Iseli TA; Solomon B; Rischin D
    Br J Cancer; 2015 Mar; 112(6):1098-104. PubMed ID: 25688737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
    Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
    Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual behaviour, HPV status and p16
    Emmett S; Boros S; Whiteman DC; Porceddu SV; Panizza BJ; Antonsson A
    J Gen Virol; 2018 Jun; 99(6):783-789. PubMed ID: 29708483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
    Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
    Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review.
    Grønhøj Larsen C; Gyldenløve M; Jensen DH; Therkildsen MH; Kiss K; Norrild B; Konge L; von Buchwald C
    Br J Cancer; 2014 Mar; 110(6):1587-94. PubMed ID: 24518594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16(INK4A) immunohistochemical staining may be helpful in distinguishing branchial cleft cysts from cystic squamous cell carcinomas originating in the oropharynx.
    Pai RK; Erickson J; Pourmand N; Kong CS
    Cancer; 2009 Apr; 117(2):108-19. PubMed ID: 19365840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients.
    Castellsagué X; Alemany L; Quer M; Halec G; Quirós B; Tous S; Clavero O; Alòs L; Biegner T; Szafarowski T; Alejo M; Holzinger D; Cadena E; Claros E; Hall G; Laco J; Poljak M; Benevolo M; Kasamatsu E; Mehanna H; Ndiaye C; Guimerà N; Lloveras B; León X; Ruiz-Cabezas JC; Alvarado-Cabrero I; Kang CS; Oh JK; Garcia-Rojo M; Iljazovic E; Ajayi OF; Duarte F; Nessa A; Tinoco L; Duran-Padilla MA; Pirog EC; Viarheichyk H; Morales H; Costes V; Félix A; Germar MJ; Mena M; Ruacan A; Jain A; Mehrotra R; Goodman MT; Lombardi LE; Ferrera A; Malami S; Albanesi EI; Dabed P; Molina C; López-Revilla R; Mandys V; González ME; Velasco J; Bravo IG; Quint W; Pawlita M; Muñoz N; de Sanjosé S; Xavier Bosch F;
    J Natl Cancer Inst; 2016 Jun; 108(6):djv403. PubMed ID: 26823521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.